Page 3 of 3
ChemComm
[1] D. M. Rudkevich, G. Hilmersson, J. Rebek Jr., J. Am. Chem. Soc.
low as 1 ꢀM (see ESI), indicating very stable assemblies. For
comparison, classical surfactants such as alkyl dimethyl-
ammonium propane sulfonates or alkyl trimethylammonium
bromides have CMC’s in the low millimolar range.[30]
1998, 120, 12216-12225.
[2] A. R. Renslo, J. Rebek Jr., Angew. Chem. 2000, 112, 3419-3421;
Angew. Chem. Int. Ed. 2000, 39, 3281-3283.
5
Currently, several anti-cancer agents are administered as
liposomal formulations in order to reduce toxic side effects of the
compounds.[31,32] However, active methods to control the release
of the encapsulated drug are still desirable. Doxorubicin
hydrochloride was chosen as a well-known and fluorescent anti-
55 [3] T. Iwasawa, E. Mann, J. Rebek Jr., J. Am. Chem. Soc. 2006, 128,
9308-9309.
[4] A. Scarso, L. Trembleau, J. Rebek Jr., J. Am. Chem. Soc. 2004, 126,
13512-13518.
10 cancer agent to investigate the ability of our vesicles to
encapsulate large hydrophilic drug molecules in their inner
aqueous compartment. Accordingly, the amphiphilic 8 was
dissolved in an aqueous solution of doxorubicin hydrochloride,
and the excess drug was separated from the vesicles by dialysis.
15 The presence of the drug in the inner aqueous compartment of the
vesicles was demonstrated by comparison of differential
interference contrast and fluorescence microscopy measurements
(Figure 6). Preliminary measurements showed a release of
doxorubicin hydrochloride upon addition of the surfactant Triton
20 X-165 (see ESI). Alternative methods of drug release, especially
those that exploit the specific recognition capabilities of the
cavities on the vesicle’s surface would also be useful.
[5] E. Biavardi, C. Tudisco, F. Maffei, A. Motta, C. Massera, G. G.
60
Condorelli, E. Dalcanale, Proc. Natl. Acad. Sci. 2012, 109, 2263-
2268.
[6] J. Kang, J. Rebek Jr., Nature 1997, 385, 50-52.
[7] L. Trembleau, J. Rebek Jr., Science 2003, 301, 1219-1220.
[8] R. J. Hooley, S. M. Biros, J. Rebek Jr., Angew. Chem. 2006, 118,
3597-3599; Angew. Chem. Int. Ed. 2006, 45, 3517-3519.
[9] M. P. Schramm, R. J. Hooley, J. Rebek, J. Am. Chem. Soc. 2007, 129,
9773-9779.
65
[10] Y. J. Kim, M. T. Lek, M. P. Schramm, Chem. Commun. 2011, 47,
9636-9638.
70 [11] S. Javor, J. Rebek Jr., J. Am. Chem. Soc. 2011, 133, 17473-17478.
[12] Y. Liu, P. Liao, Q. Cheng, R. J. Hooley, J. Am. Chem. Soc. 2010,
132, 10383-10390.
[13] K. M. Feher, H. Hoang, M. P. Schramm, New J. Chem. 2012, 36,
874-876.
75 [14] J. Voskuhl, B. J. Ravoo, Chem. Soc. Rev. 2009, 38, 495-505.
[15] S. K. M. Nalluri, J. Voskuhl, J. B. Bultema, E. J. Boekema, B. J.
Ravoo, Angew. Chem. Int. Ed. 2011, 50, 9747-9751.
[16] S. K. M. Nalluri, B. J. Ravoo, Angew. Chem. Int. Ed. 2010, 49, 5371-
5374.
80 [17] S. K. M. Nalluri, J. B. Bultema, E. J. Boekema, B. J. Ravoo, Chem.
Sci. 2011, 2, 2383-2391.
Figure 5. Confocal microscopy images of vesicles of cavitand 8 after
25 encapsulation of doxorubicin hydrochloride and dialysis. a) differential
interference contrast image; b) fluorescence microscopy image.
[18] H.-K. Lee, K. M. Park, Y. J. Jeon, D. Kim, D. H. Oh, H. S. Kim, C.
K. Park, K. Kim, J. Am. Chem. Soc. 2005, 127, 5006-5007.
[19] K. Helttunen, P. Shahgaldian, New J. Chem. 2010, 34, 2704-2714.
85 [20] Y. Tanaka, M. Miyachi, Y. Kobuke, Angew. Chem. 1999, 111, 565-
567; Angew. Chem. Int. Ed. 1999, 38, 504-506.
In conclusion, we have described an amphiphilic deep cavitand
that forms vesicles in water. These vesicles are capable of
encapsulating three different types of guests: small guest
30 molecules inside the cavities on the surface of the vesicles, larger
hydrophobic guests inside the bilayer structure and hydrophilic
guests in the inner aqueous compartment of the vesicles. The
[21] F. Bellouard, F. Chuburu, J.-J. Yaouanc, H. Handel, Y. Le Mest,
Eur. J. Org. Chem. 1999, 12, 3257-3261.
[22] S. Saito, D. M. Rudkevich, J. Rebek, Org. Lett. 1999, 1, 1241-1244.
90 [23] E. U. Thoden van Velzen, J. F. J. Engbersen, D. N. Reinhoudt, J.
Am. Chem. Soc. 1994, 116, 3597-3598.
combination offers
a promising carrier for drug delivery
applications. New methods to control the release of drug
35 molecules from the inside of the vesicles are under study,
especially those making use of the cavities on the vesicle surface.
[24] Y. Liu, T. Taira, M. C. Young, D. Ajami, J. Rebek, Q. Cheng, R. J.
Hooley, Langmuir 2012, 28, 1391-1398.
[25] W. Vogt, Free Radic. Biol. Med. 1995, 18, 93-105.
95 [26] S. M. Biros, E. C. Ullrich, F. Hof, L. Trembleau, J. Rebek, J. Am.
Chem. Soc. 2004, 126, 2870-2876.
We are grateful to the Skaggs Institute for financial support and
the Alexander von Humboldt foundation for a Feodor Lynen
40 fellowship for J. K. and the Swiss National Science Foundation
for a fellowship for S. J. We especially thank M. Wood and W. B.
Kiosses for performing the TEM and fluorescence microscopy
measurements.
[27] A. Lledó, J. Rebek Jr, Chem. Commun. 2010, 46, 8630-8632.
[28] T. Haino, D. M. Rudkevich, A. Shivanyuk, K. Rissanen, J. J. Rebek,
Chem. Eur. J. 2000, 6, 3797-3805.
100 [29] D. A. Ryan, J. Rebek, J. Am. Chem. Soc. 2011, 133, 19653-19655.
[30] D. López-Díaz, M. M. Velázquez, Chem. Educator 2007, 12, 327-
330.
Notes and references
45 Skaggs Institute for Chemical Biology, The Scripps Research Institute,
10550 North Torrey Pines Road, La Jolla, CA 92037
[31] E. Soussan, S. Cassel, M. Blanzat, I. Rico-Lattes, Angew. Chem. Int.
Ed. 2009, 48, 274-288.
† Electronic Supplementary Information (ESI) available: experimental
procedures, characterization of new compounds, 1H NMR spectra,
105 [32] T. M. Allen, P. R. Cullis, Science 2004, 303, 1818-1822.
additional TEM
50 DOI: 10.1039/b000000x/
images,
fluorescence
spectra.
See
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 3